Protease Inhibitors

To see a list of fact sheets in each category, click on the category name.

NOTE: You can see a full list of fact sheet topics on Fact Sheet 1000.

 

441. Indinavir (Crixivan)
A description of the antiretroviral drug indinavir (Crixivan), including dosing, side effects, and a general discussion of who should take this drug.
[Reviewed August 13, 2012]

442. Ritonavir (Norvir)
A description of the antiretroviral drug ritonavir (Norvir®), including dosing, side effects, and a general discussion of who should take this drug.
[Revised December 11, 2012]

443. Saquinavir (Invirase)
A description of the antiretroviral drug indinavir (Invirase), including dosing, side effects, and a general discussion of who should take this drug.
[Reviewed February 24, 2013]

444. Nelfinavir (Viracept)
A description of the antiretroviral drug nelfinavir (Viracept), including dosing, side effects, and a general discussion of who should take this drug.
[Reviewed March 10, 2013]

445. Amprenavir (Agenerase)
A description of the antiretroviral drug Amprenavir (Agenerase®), including dosing, side effects, and a general discussion of who should take this drug.
[Reviewed November 9, 2015]

446. Lopinavir + ritonavir (Kaletra)
A description of the antiretroviral drug Lopinavir (Kaletra®, Aluvia®), including dosing, side effects, and a general discussion of who should take this drug.
[Reviewed November 30, 2012]

447. Atazanavir (Reyataz)
A description of the protease inhibitor drug atazanavir (reyataz) and its use to treat HIV.
[Reviewed March 30, 2013]

448. Fosamprenavir (Telzir, Lexiva)
A description of the antiretroviral drug fosmprenavir (Lexiva®), including dosing, side effects, and a general discussion of who should take this drug.
[Revised December 14, 2012]

449. Tipranavir (Aptivus)
A description of the protease inhibitor drug tipranavir (Aptivus)and its use to treat HIV.
[Revised August 26, 2012]

450. Darunavir (Prezista)
A description of the protease inhibitor drug darunavir (Prezista) and its use to treat HIV.
[Revised December 8, 2012]